Associate Professor Ferhat Ferhatoğlu, M.D.

Career Summary:

• Muş State Hospital (Apr 2021 - Aug 2024)
• Basaksehir Cam and Sakura City Hospital, İstanbul (Aug 2021 - Mar 2023)
• Istanbul Aydın University Health Practice and Research Center (Sep 2023 - Apr 2025)
• Bahrain Oncology Center (Apr 2025 - Apr 2026)

Fields of Study:

• Personalized Treatments
• NGS and Molecular Oncology
• Prostate Cancer
• Kidney and Bladder Cancer
• Breast Cancer
• Lung Cancer
• Stomach and Colorectal Cancers
• Gynecological Cancers
• Malignant Melanoma and Sarcomas

Book Chapters:

• Targeted Therapies in Oncology Through Clinical Studies: Hepatobiliary System Tumors
• Targeted Therapies in Oncology Through Clinical Studies: Kidney Tumors
• Turkey Clinics Pediatric Hematology and Oncology – Special Topics: Fanconi Anemia and Malignancies: Chemotherapy Modifications in Fanconi Anemia Patients Who Develop Cancer
• Current Approaches to Breast Cancer: Breast Cancer in Young Women Bıology And Treatment
• Local Treatment Approaches in Breast Cancer: Inflammatory Breast Cancer
   

Projects:

• Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer
  (RECITE)
• A Study of PF-05280014 [Trastuzumab-Pfizer] or Herceptin [Trastuzumab-EU] Plus Paclitaxel in HER2 Positive First-Line Metastatic Breast Cancer Treatment
  (REFLECTIONS B327-02)

Memberships:

• Turkish Medical Association (TTB)
• Turkish Society of Medical Oncology (TTOD)
• European Society of Medical Oncology (ESMO)

Certificates:

• Experımental Anımal Use Certıfıcate (2015)
• Turkish Society of Internal Medicine Board Certificate (2017)
  Good Clinical Practice Certificate (2018) 
• Gustavo Roussy Cancer Campus (Master Class, Breast - Lung – Prostate
  Cancers), Paris, France (2018)
• Immune checkpoint inhibitör (ICPI) Treatment (ID 640907) provided by CEGOG, Vienna, Austria (2019)
• Traın The Traıners Certıfıcate (2020)
• Turkish Society of Medical Oncology Board Certificate (2021)